Clinical Trials Browser

Haematological Malignancies × MSC1992371A × Clear all

NCT01080664 2013-10-22

A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies

Phase 1 Terminated

Haematological Malignancies